Background COVID-19 infection is characterised, among other features, by a prothrombotic
state with high rate of venous thromboembolism (VTE), D-dimer, and fibrinogen levels. …

Background Primaquine is the only available drug that clears mature Plasmodium falciparum
gametocytes in infected human hosts, thereby preventing transmission of malaria to …

Background A possible association between COVID-19 infection and thrombosis, either as
a direct consequence of the virus or as a complication of inflammation, is emerging in the …

Objectives Previous studies have shown that in children with severe malaria, resuscitation
with albumin infusion results in a lower mortality than resuscitation with saline infusion. …

Background Artemisinin-based combination therapy, currently considered the therapy of
choice for uncomplicated Plasmodium falciparum malaria in endemic countries, may be under …

Indirect clinical measures assessing anti-malarial drug transmission-blocking activity in
falciparum malaria include measurement of the duration of gametocytaemia, the rate of …

Background A single low dose (0.25 mg/kg) of primaquine is recommended as a
gametocytocide in combination with artemisinin-based combination therapies for Plasmodium …

Objective Methicillin-resistant Staphylococcus aureus (MRSA) is a major problem in intensive
care units (ICU). International guidelines recommend screening patients for MRSA on …

Background Since the World Health Organization recommended single low-dose (0.25 mg/kg)
primaquine (PQ) in combination with artemisinin-based combination therapies (ACTs) in …

Artemisinin resistance is rapidly spreading in Southeast Asia. The efficacy of artemisinin-combination
therapy (ACT) continues to be excellent across Africa. We performed parasite …